AI Insight
Polycystic ovary syndrome (PCOS) has been officially renamed polycystic/polyendocrine metabolic ovarian syndrome (PMOS) to better reflect the broader endocrine and metabolic nature of the condition, moving beyond the narrow focus on ovarian cysts implied by the original name. The renaming acknowledges that the condition involves systemic hormonal and metabolic dysfunction rather than being limited to ovarian pathology. This change has been welcomed by patients and advocates who have long argued that the previous name was misleading and contributed to misunderstanding and misdiagnosis.
Why it matters
A more accurate name may improve diagnostic clarity, reduce stigma, and encourage greater awareness among both clinicians and patients, potentially leading to earlier and more appropriate treatment of a condition that affects an estimated 8 to 13 percent of women of reproductive age worldwide.
PCOS will now be known as PMOS (polyendocrine metabolic ovarian syndrome), and for Alice Klein, who has the condition, it’s been a long time coming
Source: PCOS has been officially renamed PMOS, and it’s a momentous move